SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-20-000032
Filing Date
2020-05-07
Accepted
2020-05-07 17:25:23
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xers-20200331.htm   iXBRL 10-Q 1926658
2 EX-10.3 exh103qualityassurance.htm EX-10.3 43347
3 EX-10.4 exhibit104firstamendme.htm EX-10.4 176475
4 EX-31.1 q12020exhibit311.htm EX-31.1 13616
5 EX-31.2 q12020exhibit312.htm EX-31.2 13595
6 EX-32.1 q12020exhibit321.htm EX-32.1 10289
  Complete submission text file 0001346302-20-000032.txt   6937706

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200331.xsd EX-101.SCH 39682
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200331_cal.xml EX-101.CAL 38840
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200331_def.xml EX-101.DEF 267043
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200331_lab.xml EX-101.LAB 526923
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200331_pre.xml EX-101.PRE 359506
20 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200331_htm.xml XML 997736
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 20857752
SIC: 2834 Pharmaceutical Preparations